CorMedix Scheduled to Report Third Quarter Earnings on November 12
CorMedix (CRMD) is set to release its third-quarter financial results before the market opens on Thursday, November 12. Market analysts have established a consensus earnings per share (EPS) estimate of -$0.11 and a revenue projection of $52.77 million, which represents a significant year-over-year decline of approximately 49.4%. Historically, the company has shown mixed performance regarding analyst expectations, beating EPS estimates in 25% of cases over the past year and exceeding revenue forecasts in 50% of instances. Investors will be looking for guidance following recent developments, including FDA priority review for Rezzayo label expansion and previous volatility driven by Q2 earnings beats.
Tickers: $CRMD
Topics: earnings announcement EPS estimates revenue estimates
Read the full article at Seeking Alpha
Part of the story Lowe's Companies to Host Third Quarter 2026 Earnings Conference Call on November 18 (5 articles)